{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:51:28Z","timestamp":1771674688204,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Immunosuppressed patients have worse outcomes from cutaneous squamous cell carcinomas (cSCCs), although unclear whether it is due to the development of more high-stage tumors or worse outcomes for a given stage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Analyze the impact of immunosuppression on the development of cSCCs and tumor stage\u2013dependent outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Single-institution 1:2 case\u2013control study of primary invasive cSCCs from 2005 to 2015 in 106 mixed-cause immunosuppressed patients and 212 control subjects matched to age, gender, and race.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Four hundred twelve cSCCs from 106 immunosuppressed patients and 291 tumors from 212 matched immunocompetent patients were included. Both cohorts had similar T-stage distribution, with &lt;5% high-stage tumors, that is, AJCC-7 T2, AJCC-8 T3, and BWH T2b\/T3. Immunosuppression significantly increased the likelihood of poor outcomes (POs) (aggregate of local recurrence (LR), nodal and distant metastasis, and squamous cell carcinoma\u2013related deaths) for low-stage tumors, that is, AJCC-7 T1 (odds ratio [OR], 4.29), AJCC-8 T1 (OR, 3.45), AJCC-8 T2 (OR, 3.75), BWH T1 (OR, 3.53), and BWH T2a (OR, 3.41) tumors. There was no significant difference in the treatment: most tumors were treated with Mohs (71% vs 75%) or excision (21% vs 20%) in both cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Immunosuppressed patients have an increased risk of POs, specifically LRs, from low-stage cSCCs. Definitive treatment of cSCCs is recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000001930","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:53:16Z","timestamp":1554684796000},"page":"1467-1476","source":"Crossref","is-referenced-by-count":10,"title":["Case\u2013Control Study of Tumor Stage\u2013Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients"],"prefix":"10.1097","volume":"45","author":[{"given":"Jessica L.","family":"Gonzalez","sequence":"first","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiera","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Silverman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Madan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bichchau Michelle","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2012.01.010","article-title":"The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients","volume":"67","author":"Metchnikoff","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaad.2015.04.037","article-title":"Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy","volume":"73","author":"Manyam","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamadermatol.2013.6249","article-title":"Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia","volume":"150","author":"Velez","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am J Transpl"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11864-016-0435-z","article-title":"Management of skin cancer in the high-risk patient","volume":"17","author":"Behan","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/DSS.0000000000001038","article-title":"Comparison of the American Joint Committee on cancer Seventh Edition and Brigham and Women's Hospital cutaneous squamous cell carcinoma tumor staging in immunosuppressed patients","volume":"43","author":"Gonzalez","year":"2017","journal-title":"Dermatol Surg"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint committee on cancer, International Union against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/ajt.14238","article-title":"Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients","volume":"17","author":"Krisl","year":"2017","journal-title":"Am J Transplant"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaad.2005.10.049","article-title":"Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series","volume":"54","author":"Harwood","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/TP.0b013e3181ec7228","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients","volume":"90","author":"Lott","year":"2010","journal-title":"Transplantation"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40257-016-0207-3","article-title":"Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease","volume":"17","author":"Burton","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0033-1353381","article-title":"Skin cancer in immunosuppressed patients","volume":"29","author":"Gordon Spratt","year":"2013","journal-title":"Facial Plast Surg"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.94323","article-title":"Nonmelanoma skin cancer","volume":"5","author":"Samarasinghe","year":"2012","journal-title":"J Cutan Aesthet Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:02:09Z","timestamp":1692043329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001930","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}